+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Molecular characterization of human B domain-specific anti-factor VIII monoclonal antibodies generated in transgenic mice



Molecular characterization of human B domain-specific anti-factor VIII monoclonal antibodies generated in transgenic mice



Thrombosis and Haemostasis 98(1): 138-147



The development of antibodies directed against factor VIII (FVIII) represents a major hurdle in the treatment of hemophilia A. Most anti-FVIII antibodies are identified through their ability to inhibit the FVIII procoagulant activity. Many of them, however, do not interfere with the functional properties of FVIII. Antibodies directed against the B domain belong to this latter category. Here, we characterized B domain-specific human monoclonal Abs (mAbs) at the molecular level. A series of human mAbs directed against FVIII was produced upon immunization of transgenic XenoMouse mice with human recombinant FVIII (rFVIII). Selection of the hybridoma with epitope specificity for the B domain was performed by differential recognition of full-length and B domain-deleted rFVIII. None of the anti-B domain mAbs demonstrated inhibitory activity against FVIII. Three of the mAbs recognized linear epitopes: mAb 25H3 bound to the (1014)HIDGPSLLIEN(1024) sequence; mAbs 8E3 and 22B6 shared the same epitope, composed of residues (1534)KWNEANR(1540). The corresponding soluble peptides inhibited the binding of their respective mAbs to FVIII. mAbs 8E3 and 22B6 displaced the binding of FVIII to vonWillebrand factor. Moreover, some of them (in particular mAbs 4G6 and 8E3) were able to compete for binding to the B domain with the anti-FVIII Abs from hemophilia A patients without inhibitor or with low Bethesda titers. Further investigation will allow to better characterize their clinical relevance.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 016407780

Download citation: RISBibTeXText

PMID: 17598006

DOI: 10.1160/th06-09-0510


Related references

Domain specific monoclonal anti-factor VIII antibodies generated by inclusion body-renatured factor VIII peptides. Thrombosis Research 101(5): 405-415, 2001

Characterization of Entamoeba histolytica intermediate subunit lectin-specific human monoclonal antibodies generated in transgenic mice expressing human immunoglobulin loci. Infection and Immunity 77(1): 549-556, 2009

Factor VIII inhibitors and anti-factor VIII monoclonal anti-bodies recognizing A2 domain in human factor VIII heavy chain poorly bind to porcine factor VIII. Blood 84(10 Suppl. 1): 67A, 1994

Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies. Proceedings of the National Academy of Sciences of the United States of America 87(21): 8232-8236, 1990

Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain. Journal of Clinical Investigation 82(1): 123-128, 1988

Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor. Biotechnology Progress 17(6): 1119-1127, 2001

Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci. European Journal of Immunology 35(6): 1960-1968, 2005

A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting. Thrombosis and Haemostasis 67(6): 665-671, 1992

Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain. Blood 96(2): 540-545, 2000

Syngeneic anti idiotypic monoclonal antibodies to murine anti human high molecular weight melanoma associated antigen hmw maa monoclonal antibodies immunochemical characterization and clinical applications. Tumor Biology 8(6): 343, 1987

Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII. Journal Of Immunological Methods. 210(2): 205-214,. 29, 1997

Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII. Journal of Immunological Methods 210(2): 205-214, 1997

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. Journal of Clinical Investigation 83(6): 1978-1984, 1989

Antibodies to idiotypes of human monoclonal anti-factor VIII antibodies neutralise their inhibitory activity. Blood 94(10 Suppl. 1 Part 1): 460a, 1999

Anti-IL-4 and anti-IL-13 specific hybridoma cells generated in cytokine-deficient mice show absolute dependence of IL-6 and produce low affinity IgMkappa monoclonal antibodies. Journal of Leukocyte Biology Suppl. ( ): 73, 2001